Objective: The association between increased amniotic fluid interleukin-6 (IL-6) concentrations and preterm labor has received increasing attention. Several research groups have evaluated this association using commercial IL-6 kits, which .principally use the sandwich-enzyme-immunoassay method, and were originally created to measure IL-6 in plasma, serum, or culture media. We evaluated commercial kits for the determination of IL-6 in amniotic fluid.
nterleukin-6 (IL-6) is a multifunctional protein and an inducer of the acute-phase response. It is produced by a variety of cells, and its production is stimulated by infections. 1, 2 Increasing information has become available on the association between amniotic fluid IL-6 concentrations and pregnancy outcome. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] Several groups of investigators have used commercial kits for the measurement of IL-6 in amniotic fluid. 3'7'8'-2'14 However, these kits were originally intended to measure IL-6 in plasma, serum, and tissue-culture media, not in amniotic fluid. To evaluate various kits for the measurement of IL-6 in amniotic fluid, we used seven commercially available kits and compared the results of the concentrations of amniotic fluid IL-6. 
MATERIALS AND METHODS

RESULTS
The source, standard range, and characteristics of the commercial kits are summarized in Table 1 .
Some kits were more labor intensive than others. As shown in samples, because these kits were originally created for the measurement of IL-6 in plasma, serum, or tissue-culture media. Our data indicate that commercially available kits can be successfully used to measure IL-6 in amniotic fluid, since it was possible to distinguish the samples with high IL-6 levels from those with low IL-6 levels with all kits used in this study.
However, the values obtained using the seven kits in this study were quite different, indicating that it is unreasonable to compare values obtained using different kits in various laboratories. There are several possible explanations for these discrepancies among the kits. These include: 1) differences in the antibodies to IL-6 among kits which may have different responses to allotropes of IL-6 produced by various tissues, as pointed out by Bienvenu et al.lS; 2) the protein matrix in amniotic fluid which affects antibody reactivity to IL-6 in assay kits originally prepared for the measurement of IL-6 in plasma, serum, or culture media; and 3) differences in the preparation of the standard used in each kit. No instruction stated how the concentrations of the standard were calibrated for the preparation of the kits.
In conclusion, it is essential that normal ranges be established for IL-6 concentrations in amniotic fluid for each kit used in each laboratory. In order to compare the values from various laboratories, it is desirable to standardize the method to measure IL-6 in amniotic fluid.
